An audit desk for a market that didn't have one.

The research-peptide market grew faster than the publications covering it could keep up. Most vendor reviews you can find are written by people the vendors paid — sometimes openly, more often as “influencer” arrangements buried in fine print.

We started vialaudit because we got burned ourselves. Now we run the protocol we wished existed: order anonymously, send to a third-party lab, publish what the chromatograms say.

• Run quarterly audit cycles on every vendor we cover.
• Publish vendor profiles, peptide guides, and head-to-head comparisons.
• Maintain a live coupon directory with verified, non-expired codes.
• Send one email a month with new audits and pruned coupons.

• Sell peptides. We are a publication, not a vendor.
• Provide medical advice or recommend dosing for human use.
• Accept retainers, sponsored content, or paid feature placements.
• Allow vendors to review their audits before publication.

Editorial is a small team of writers and one analyst running the audits. Lab work rotates between two independent partners we don't identify publicly so vendors can't pre-screen samples by lab signature.

Most contributors write under pen names. The grey-market context makes real-name bylines impractical for the writers and risky for the labs. The tradeoff is real and we'd rather work pseudonymously than not at all.

For corrections, tips on vendors we should audit, or pitches: tips@vialaudit.com. For affiliate program inquiries: partnerships@vialaudit.com.